Healthcare Services & Providers

Latham & Watkins’ lawyers have expertise in the entire spectrum of legal and business challenges facing the healthcare services and providers sector.

Why Latham

Industry Insight and Experience

With a dedicated Healthcare Services & Providers Industry Group operating across the United States, Europe, Asia and the Middle East, more than 120 lawyers in the group utilize their industry knowledge, legal expertise, commercial and government insights to help clients navigate an increasingly complex landscape.

Latham advises sophisticated hospital, health system, provider and payor clients, financial investors and other players in the healthcare sector dealing with challenging transactional, investigatory, litigation, antitrust and competition, and regulatory issues.

The group possesses years of experience advising a range of healthcare industry businesses, including:

  • Hospitals, academic medical centers, healthcare systems
  • Managed care providers, integrated delivery systems
  • Health insurance companies, health plans and other payor organizations
  • Skilled nursing facilities, assisted living facilities, home health agencies
  • Physician organizations
  • Rehabilitation, diagnostic, and other ancillary service providers
  • Countries, states, municipalities, and other government and government-sponsored agencies operating healthcare sector enterprises
  • Healthcare trade associations
  • Financial investors, investment banks, institutional lenders, private equity firms, venture capital firms and others with focus on the healthcare sector

The unique breadth of the industry group's experience and client base affords a deep understanding of the industry, allowing its lawyers  to offer superior counsel to clients involved in transactions, investigations, litigation, antitrust and competition, and regulatory issues. With a highly developed grasp of the regulatory environments and markets clients face around the world, Latham lawyers offer clients careful and practical guidance that meets their business needs.

Interdisciplinary Approach

Latham's lawyers have handled some of the most significant hospital and healthcare provider investigations — including investigations of nation-wide operators.  The firm's lawyers have also worked on many of the largest healthcare industry transactions around the globe. Latham regularly helps clients address issues relating to a wide spectrum of legal challenges, including:

Our Experience

Because healthcare legal issues extend beyond healthcare law, Latham lawyers across the firm support healthcare clients in all areas of their business. Additional services offered by the firm include:

  •  Antitrust and trade regulation
  • Competition law
  • Corporate transactions and securities laws
  • Conventional and tax-exempt financing
  • Environmental law
  • Federal Emergency Management Agency (FEMA) negotiations
  • Intellectual property
  • Labor, employment, pensions and employment retirement (e.g. ERISA)
  • Real estate and land use
  • Restructurings, bankruptcies and workouts
  • Subsidies
  • Securitization of healthcare receivables
  • Tax and tax-exemption laws (e.g. non-profit organizations)

Awards & Rankings


  • Latham Again Named Technology Group of the Year - February 18, 2019
  • Latham Named Life Sciences Practice Group of the Year - January 27, 2019
  • Five Partners Receive 2018 MVP Recognition from Law360 - November 25, 2018
  • Latham Honored as Capital Markets Practice Group of the Year - January 21, 2018
  • Latham Partners Honored for Leadership in Los Angeles - November 02, 2017

Latham has an “esteemed healthcare practice offering capabilities across the spectrum of healthcare matters, including high-value transactions, litigation, regulatory compliance and governmental enforcement.” The firm has "very strong expertise in the healthcare arena. They know what they're doing and have the right resources to bring to bear."

– Chambers USA 2018

Events

Webcast: Recent Developments in Health Care Enforcement

Media Coverage

Latham Named Life Sciences Practice Group of the YearClinical Trials Under the GDPR: What Should Sponsors Consider? Latham Leads Firms in IPO Deals After Market's Robust Year

News

Latham Named Life Sciences Practice Group of the YearLatham Advises Sistema on its Acquisition of an Equity Interest in OBL PharmLatham Successfully Protects Sinovac Biotech’s Board of Directors

Thought Leadership

Clinical Trials Under the GDPR: What Should Sponsors Consider? FDA Announces Planned Changes to the 510(k) Premarket Notification ProgramOIG Provides Regulatory Considerations for Gainsharing Agreements in Advisory Opinion 17-09